Annual Revenue
$6.13 M
-$45.50 M-88.13%
December 31, 2022
Summary
- As of February 10, 2025, KDNY annual revenue is $6.13 million, with the most recent change of -$45.50 million (-88.13%) on December 31, 2022.
Performance
KDNY Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Revenue
$1.01 M
-$820.00 K-44.86%
June 30, 2023
Summary
- As of February 10, 2025, KDNY quarterly revenue is $1.01 million, with the most recent change of -$820.00 thousand (-44.86%) on June 30, 2023.
- Over the past year, KDNY quarterly revenue has increased by +$590.00 thousand (+141.15%).
Performance
KDNY Quarterly Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Related metrics
TTM Revenue
$5.85 M
+$590.00 K+11.22%
June 30, 2023
Summary
- As of February 10, 2025, KDNY TTM revenue is $5.85 million, with the most recent change of +$590.00 thousand (+11.22%) on June 30, 2023.
- Over the past year, KDNY TTM revenue has dropped by -$48.51 million (-89.24%).
Performance
KDNY TTM Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
KDNY Revenue Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -88.1% | +141.2% | -89.2% |
| 3 y3 years | - | - | - |
| 5 y5 years | - | -79.0% | +166.3% |
KDNY Revenue Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -88.1% | at low | -98.0% | -58.5% | -89.7% | -10.1% |
| 5 y | 5-year | -88.1% | -86.5% | -98.0% | -1451.7% | -89.7% | -250.9% |
| alltime | all time | -88.1% | -86.5% | -98.0% | -1451.7% | -89.7% | -250.9% |
Chinook Therapeutics Revenue History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2023 | - | $1.01 M(-44.9%) | $5.85 M(+11.2%) |
| Mar 2023 | - | $1.83 M(+257.0%) | $5.26 M(-14.2%) |
| Dec 2022 | $6.13 M(-88.1%) | $512.00 K(-79.5%) | $6.13 M(-89.2%) |
| Sep 2022 | - | $2.50 M(+498.3%) | $56.85 M(+4.6%) |
| Jun 2022 | - | $418.00 K(-84.5%) | $54.35 M(+0.7%) |
| Mar 2022 | - | $2.70 M(-94.7%) | $53.97 M(+4.5%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2021 | $51.63 M(+6142.4%) | $51.24 M(>+9900.0%) | $51.63 M(+4145.5%) |
| Sep 2021 | - | $4000.00(-88.2%) | $1.22 M(+0.3%) |
| Jun 2021 | - | $34.00 K(-90.3%) | $1.21 M(+2.9%) |
| Mar 2021 | - | $351.00 K(-57.6%) | $1.18 M(+42.4%) |
| Dec 2020 | $827.00 K | $827.00 K(-106.1%) | $827.00 K(-109.4%) |
| Dec 2019 | - | -$13.63 M(-383.9%) | -$8.83 M(-283.9%) |
| Sep 2019 | - | $4.80 M | $4.80 M |
FAQ
- What is Chinook Therapeutics annual revenue?
- What is the all time high annual revenue for Chinook Therapeutics?
- What is Chinook Therapeutics annual revenue year-on-year change?
- What is Chinook Therapeutics quarterly revenue?
- What is the all time high quarterly revenue for Chinook Therapeutics?
- What is Chinook Therapeutics quarterly revenue year-on-year change?
- What is Chinook Therapeutics TTM revenue?
- What is the all time high TTM revenue for Chinook Therapeutics?
- What is Chinook Therapeutics TTM revenue year-on-year change?
What is Chinook Therapeutics annual revenue?
The current annual revenue of KDNY is $6.13 M
What is the all time high annual revenue for Chinook Therapeutics?
Chinook Therapeutics all-time high annual revenue is $51.63 M
What is Chinook Therapeutics annual revenue year-on-year change?
Over the past year, KDNY annual revenue has changed by -$45.50 M (-88.13%)
What is Chinook Therapeutics quarterly revenue?
The current quarterly revenue of KDNY is $1.01 M
What is the all time high quarterly revenue for Chinook Therapeutics?
Chinook Therapeutics all-time high quarterly revenue is $51.24 M
What is Chinook Therapeutics quarterly revenue year-on-year change?
Over the past year, KDNY quarterly revenue has changed by +$590.00 K (+141.15%)
What is Chinook Therapeutics TTM revenue?
The current TTM revenue of KDNY is $5.85 M
What is the all time high TTM revenue for Chinook Therapeutics?
Chinook Therapeutics all-time high TTM revenue is $56.85 M
What is Chinook Therapeutics TTM revenue year-on-year change?
Over the past year, KDNY TTM revenue has changed by -$48.51 M (-89.24%)